Luteolin

For research use only.

Catalog No.S2320

8 publications

Luteolin Chemical Structure

Molecular Weight(MW): 286.24

Luteolin is a flavonoid found in Terminalia chebula, which is a non-selective phisphodiesterase PDE inhibitor for PDE1-5 with Ki of 15.0 μM, 6.4 μM, 13.9 μM, 11.1 μM and 9.5 μM, respectively. Phase 2.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 70 In stock
USD 50 In stock
USD 170 In stock
USD 570 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Luteolin has been cited by 8 publications

1 Customer Review

  • Bioactive compounds inhibit recombinant HDAC activity. Recombinant HDACs were incubated with flavonoid Luteolin (C) for 2 h prior to the addition of cell permeable HDAC substrates. Luteolin inhibited activity of most classes I, IIa, and IIb HDAC isoforms.

    Mol Nutr Food Res, 2017, doi: 10.1002/mnfr.201600744. Luteolin purchased from Selleck.

Purity & Quality Control

Choose Selective ADC Cytotoxin Inhibitors

Biological Activity

Description Luteolin is a flavonoid found in Terminalia chebula, which is a non-selective phisphodiesterase PDE inhibitor for PDE1-5 with Ki of 15.0 μM, 6.4 μM, 13.9 μM, 11.1 μM and 9.5 μM, respectively. Phase 2.
Targets
PDE2 [1]
(Cell-free assay)
PDE5 [1]
(Cell-free assay)
PDE4 [1]
(Cell-free assay)
PDE3 [1]
(Cell-free assay)
PDE1 [1]
(Cell-free assay)
6.4 μM(Ki) 9.5 μM(Ki) 11.1 μM(Ki) 13.9 μM(Ki) 15.0 μM(Ki)
In vitro

Luteolin is a flavonoid found in Terminalia chebula, which is a non-selective phisphodiesterase PDE inhibitor for PDE1-5 with Ki of 15.0 μM, 6.4 μM, 13.9 μM, 11.1 μM and 9.5 μM, respectively. [1] Luteolin inhibits LPS-stimulated TNF-alpha production with an IC50 of less than 1 μM. Luteolin inhibites LPS-induced phosphorylation of Akt as well as IkappaBalpha. [2]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
mouse RAW264.7 cells NXvBVWVOTnWwY4Tpc44h[XO|YYm= NUnvRmFnOiCq MXjJcohq[mm2aX;uJI9nKE6RIIDyc4R2[3Srb36gbY4hVFCVLYP0bY12dGG2ZXSgcY92e2ViUlHXNlY1NjdiY3XscJMheHKnLXnuZ5Vj[XSnZDDmc5IhOiCqcoOgZoVnd3KnIFzQV{B{fGmvdXzheIlwdiCob4KgNlQhcHK|IHL5JGdzcWW|czDhd5NigSCvZYToc4QtKEmFNUC9NE4zOSEQvF2= NVTRfIZ2OjVzN{[xPFc>
HEK293 FS cells MkO1SpVv[3Srb36gZZN{[Xl? NWjTUFA2UW6qaXLpeIlwdiCxZjDOU3g1KGW6cILld5Nm\CCrbjDISWszQTNiRmOgZ4VtdHNiYYPz[ZN{\WRiYYOgTFJQOiCycn;keYN1cW:wIHL5JGgzVzJxVInyM2xRVyCjc4PhfUwhUUN3ME2wMlg2KM7:TR?= Mk\sNlA4OzF|NUe=
CHO cells NILJdHBHfW6ldHnvckBie3OjeR?= MXPB[49vcXO2IHHjeIl3cXS7IHH0JJJifCCGQWSg[ZhxemW|c3XkJIlvKEOKTzDj[YxteyxiRVO1NF0yNjR3IN88US=> MUmyNFk4OTZ3MB?=
human MV4-11 cells MX\DfZRwfG:6aXPpeJkh[XO|YYm= NEPBUGY4OiCq M1;kbGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1XPC1zMTDj[YxteyCqYYLic5JqdmdiRlzUN{BufXSjdHnvckBi\nSncjC3NkBpenNiYomgeIV1emG8b3zpeY0h[mG|ZXSgSZohS3mWb4igZ4VtdCC4aXHibYxqfHliYYPzZZktKEeLNUC9NU44PiEQvF2= MnzrNlM1OTFyN{O=
HEK293 cells MVXGeY5kfGmxbjDhd5NigQ>? MYiyOEBp Mmj4RYdwdmm|dDDhZ5Rqfmm2eTDheEBud3W|ZTDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDjc{1mgHC{ZYPzbY5oKHerdHigS4FtPCC{ZYDvdpRmeiC4ZXP0c5Ih[W[2ZYKgNlQhcHK|IHL5JIR2[WxvbIXjbYZmemG|ZTDy[ZBwenSncjDhd5NigSxiRVO1NF0zNjNizszN NEfqPYkzPDl3NUi4PS=>
human U2OS cells NXz4WYpnTnWwY4Tpc44h[XO|YYm= M2H3fVUhcA>? MnrQRYdwdmm|dDDhZ5Rqfmm2eTDheEBIWFJ|NTDy[YNmeHSxcjDpckBpfW2jbjDVNm9UKGOnbHzzJINw\XiycnXzd4lv\yCJYXy0MXZROTZvVFXWJIF{e2W|c3XkJIF{KGKndHGgZZJz\XO2aX6geJJidnOub3PheIlwdiCjZoTldkA2KGi{czDifUBj\XSjIHzhZ5RidWG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUOuNkDPxE1? Mkf1NlQ6ODB2NEe=
RBL-2H3 cells MoLtSpVv[3Srb36gZZN{[Xl? MmDpTY5pcWKrdH;yfUBi[3Srdnn0fUBi\2GrboP0JGlNNTRicILv[JVkfGmxbjDpckBTSkxvMlizJINmdGy|IIfhd{Bl\XSncn3pcoVlNCCLQ{WwQVMvPyEQvF2= NFXTNm4yOjl3MUC5Ni=>
human mast cells NWDsdVBJTnWwY4Tpc44h[XO|YYm= NVP5SmpTUW6qaXLpeIlwdiCxZjDTXWshcW5iaIXtZY4hdWG|dDDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4hdWG|dDDj[YxtKGSnZ4LhcpVt[XSrb36sJGVEPTB;ND61JO69VQ>? MmrWNlIzPTd{MUO=
human LNCAP cells MlXwSpVv[3Srb36gZZN{[Xl? NYS1UWtETG:5boLl[5Vt[XSrb36gc4YheHKxc4TheIUhe3CnY3nmbYMh[W62aXflckB{\WO{ZYTpc44hcW5iaIXtZY4hVE6FQWCgZ4VtdHNuIFnDOVA:PSEQvF2= Mk\1NlUxOTl2N{i=
rat H9c2 cells MXLGeY5kfGmxbjDhd5NigQ>? MkH2NlQhcA>? M3PpRmN6fG:ycn;0[YN1cX[nIHHjeIl3cXS7IHHnZYlve3RiZH;4c5J2[mmlaX6tbY5lfWOnZDDjfZRwfG:6aXPpeJkhcW5icnH0JGg6[zJiY3XscJMh[XO|ZYPz[YQh[XNiY3XscEB3cWGkaXzpeJkh[W[2ZYKgNlQhcHK|IHL5JG1VXCCjc4PhfUwhTUN3ME21MlU{KM7:TR?= NXfm[|ZROjB7M{K3OlI>
human HT-29 cells MoX3SpVv[3Srb36gZZN{[Xl? MUexNEBucW6| NV;ScYxQSWexbnnzeEBi[3Srdnn0fUBifCCJUGKzOUBz\WOncITvdkBqdiCqdX3hckBJXC1{OTDj[YxteyCjZoTldkAyOCCvaX7zJIJ6KGS7bnHtbYMhdWG|czDy[YRqe3S{aXL1eIlwdiCjc4PhfUwhTUN3ME23MlI1KM7:TR?= M3Kxe|I1QTByNES3
human RS4:11 cells NXvYZ|l4S3m2b4TvfIlkcXS7IHHzd4F6 NGfNcmY4OiCq NIrwU4REgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBTWzR8MUGgZ4VtdHNiaHHyZo9zcW6pIIfpcIQhfHmyZTDGUHQ{KGGodHXyJFczKGi{czDifUB1\XS{YYrvcIl2dSCkYYPl[EBGgiCFeWTvfEBk\WyuII\pZYJqdGm2eTDhd5NigSxiR1m1NF04NjJ3IN88US=> NHuyXFgzOzRzMUC3Ny=>
NCI-H460 cells NUPsNHo{TnWwY4Tpc44h[XO|YYm= MV[yMVIxKGh? MnPiTY5pcWKrdHnvckBw\iCDQlPHNkBmgHC{ZYPz[YQhcW5iaIXtZY4hVkOLLVi0OlAh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDQbGEh[WOldX31cIF1cW:wIHHmeIVzKDJidH:gNlAhcHK|IILlcIF1cX[nIITvJIZ2dWm2cnXtc5JocW5iQzygTWM2OD16Lkmg{txO MXeyNVI4PTN6Nh?=
human H9 cells M{TGdWZ2dmO2aX;uJIF{e2G7 M4L3d|Mh\GG7cx?= Mk\5RY51cX[rcnHsJIFkfGm4aYT5JIFo[Wmwc4SgTGlXOSB|QjDpcoZm[3SnZDDpckBpfW2jbjDIPUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oII\pdoFtKHKncHzpZ4F1cW:wIHHmeIVzKDNiZHH5d{BjgSCyMkSgZY51cWenbjDjZZB1fXKnIHHzd4F6NCCHQ{WwQVExKM7:TR?= MoPkPFE2QDF4NB?=
MDCK cells NEPR[JFEgXSxdH;4bYNqfHliYYPzZZk> NILWWVJEgXSxdH;4bYNqfHliYXfhbY5{fCCPRFPLJINmdGy|IHL5JG1VXCCjc4PhfUwhS0N3ME2xNk41PCEQvF2= NFPM[pkyQDZ2MEC0Ni=>
mouse B16-4A5 cells MknZSpVv[3Srb36gZZN{[Xl? MYK3NkBp Ml\DTY5pcWKrdHnvckBw\iC2aHXvdIh6dGyrbnWtd5RqdXWuYYTl[EBu\Wyjbn;n[Y5me2m|IHnuJI1wfXOnIFKxOk01STViY3XscJMh[W[2ZYKgO|IhcHK|LDDJR|UxRTF2IN88US=> MmfONlAyQDl|OUm=
K562 cells NUHFNZA6T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M1TIPVUh\GG7cx?= NGf1dYxIem:5dHigbY5pcWKrdHnvckBw\iCNNU[yJINmdGy|IHL5JHhVXCCjc4PhfUBi\nSncjC1JIRigXNuIFnDOVA:OTRwNkWg{txO NI\IfVMyPzRzMUC5Ni=>
human H9 cells NETEWFdEgXSxdH;4bYNqfHliYYPzZZk> NFPqcVM{KGSjeYO= Ml[yR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTFkh[2WubIOgZYZ1\XJiMzDkZZl{NCCLQ{WwQVE3KM7:TR?= MV64NVU5OTZ2
human HT-29 cells MVrGeY5kfGmxbjDhd5NigQ>? NF6wfXoyOCCvaX7z NFLQN2xF\XOnboPpeIl7[XSrb36gc4YhT1CUM{WgdoVk\XC2b4KgbY4hcHWvYX6gTHQuOjliY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kB7[XC{aX7hd5QucW6mdXPl[EBlgW6jbXnjJI1ie3NicnXkbZN1emmkdYTpc44h[W[2ZYKgNVAhdWmwczygTWM2OD1zOD62JO69VQ>? NXfmdnJ4OjR7MEC0OFc>
human U937 cells NH;rZ5RRem:uaX\ldoF1cW:wIHHzd4F6 MUW3NkBp Mmq2RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCXOUO3JINmdGy|IHHmeIVzKDd{IHjyd{BjgSCZU2StPEBie3OjeTygTWM2OD1{MDFOwG0> MmnhNVcyPThyNUS=
mouse HT22 cells NFr1XpFHfW6ldHnvckBie3OjeR?= NXPwOndJOyCq M3n5Rm5mfXKxcILveIVkfGm4ZTDhZ5Rqfmm2eTDpckBud3W|ZTDIWFIzKGOnbHzzJIF{e2W|c3XkJIF{KHRvQl;PTE1qdmS3Y3XkJJRwgGmlaYT5JIF1KDRyIIXNJJBz\WmwY4XiZZRm\CCob4KgN{BpenNiZn;scI94\WRiYomgeE1DV0:KIHnu[JVkfGmxbjDt[YF{fXKnZDDh[pRmeiB7IHjyd{BjgSCPVGSgZZN{[Xl? Mli5NlQzPDV7M{m=
human THP1 cells MV\GeY5kfGmxbjDhd5NigQ>? NVnTOYxVOjBizszN MYqxJIg> NHr2SXVFd3ewcnXneYxifGmxbjDv[kBVWEFvaX7keYNm\CCQT2iyJI1TVkFiZYjwdoV{e2mxbjDpckBpfW2jbjDUTHAyKGOnbHzzJIF1KDJyIIXNJIlv[3WkYYTl[EBnd3JiMTDodkBxemmxcjD0c{BVWEFiY3jhcIxmdmenIH3lZZN2emWmIHHmeIVzKDJ2IHjyd{BjgSCUVD3QR3Ih[W6jbInzbZM> M3fCXVI{Pzh4NUKw
MDA-MB-231 cells MoGxSpVv[3Srb36gZZN{[Xl? NFLBdpA2KM7:TR?= NGrZeFMyPiCq M3nsdGlvcGmkaYTpc44hd2ZiUF3BMZN1cW23bHH0[YQhVkZva3HwdIFDKHOrZ37hcIlv\yBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDNSGEuVUJvMkOxJINmdGy|IHH0JFUhfU1iaX7jeYJifGWmIH\vdkAyPiCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7 NVvxdZRJOjVzOUC0OlY>
HL60 cells MnzuVJJwdGmoZYLheIlwdiCjc4PhfS=> M2D0RVMxKM7:TR?= NHftRYM1QCCq M2fMVGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFy2NEBk\WyuczDheEA{OCC3TTDh[pRmeiB2ODDodpMh[nliTWTTJIF{e2G7 MkDhNVgzPTh2NEC=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
FADD / PARP / Cleaved PARP ; 

PubMed: 30992674     


LN229 cells were exposed to luteolin (0, 10, 20, and 30 µM) for 24 hours; the levels of FADD, PARP, and cleaved PARP were then measured by Western blot analysis.

Caspase-3 / Cleaved Caspase-3 / Caspase-8 / Cleaved Caspase-8 ; 

PubMed: 30992674     


LN229 cells were exposed to luteolin (0, 10, 20, and 30 µM) for 24 hours; the levels of Caspase-8, cleaved Caspase-8, Caspase-3, and cleaved Caspase-3 were measured by Western blot analysis. 

ERK / p-ERK / JNK / p-JNK / p38 / p-p38 / Bax / Bcl-2 ; 

PubMed: 30992674     


LN229 cells were treated with luteolin (0, 10, 20, and 30 µM) for 24 hours, and Western blot analysis was performed to measure the expression levels of ERK, P-ERK, JNK, P-JNK, p38, P-p38, Bax, and Bcl-2. 

p-VEGFR2 / p-mTOR / pS6K1 / p70S6K1 / pAKT / AKT / MMP-2 / MMP-9 ; 

PubMed: 23300633     


Luteolin suppressed the activation of VEGFR2 and their downstream signaling pathway triggered by VEGF in HUVECs. Proteins from different treatments was tested by Western blotting and probed with specific antibodies. Experiments were repeated for three times. 

p21 / Survivin / Cyclin D1; 

PubMed: 30930986     


Total protein was isolated from control and luteolin-treated MDA-MB-231 cells, and subjected to immunoblotting of p21, Survivin and cyclin D1 proteins. Membranes were stripped and re-probed with anti-GAPDH antibody to ensure equal protein loading. p21 was upregulated, whereas Survivin and cyclin D1 were downregulated in MDA-MB-231 cell in a dose-dependent manner. *P<0.05 vs. the control group (0 µM luteolin); #P<0.05 vs. the 10 µM luteolin group.

DNMT1 / DMNT3A / DNMT3B ; 

PubMed: 30988303     


Cells were treated with various concentrations (0–60 μM) of luteolin for 48 h Western blot analysis was performed using antibodies against DNMT1, DNMT3A, DNMT3B.

TET1 / TET2 / TET3 ; 

PubMed: 30988303     


Cells were treated with various concentrations (0–60 μM) of luteolin for 48 h Western blot analysis was performed using antibodies against TET1, TET2, and TET3.

30992674 23300633 30930986 30988303
Immunofluorescence
5-hmC ; 

PubMed: 30988303     


Formation of 5-hmC by TETs was assessed using confocal imaging.

30988303
Growth inhibition assay
Cell viability; 

PubMed: 30992674     


(B) LN229 cells were incubated with different concentrations of luteolin for 24 and 48 hours, and then the cell viability was measured by CCK-8 assay. (C) U251 cells were incubated with different concentrations of luteolin for 24 and 48 hours, and then the cell viability was measured by CCK-8 assay. (D) HEB cells were incubated with different concentrations of luteolin for 24 and 48 hours, and then the cell viability was measured by CCK-8 assay.

30992674
In vivo LD50: Mice >2500mg/kg (i.g.) [3]

Protocol

Solubility (25°C)

In vitro DMSO 57 mg/mL (199.13 mM)
Ethanol 3 mg/mL warmed (10.48 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 286.24
Formula

C15H10O6

CAS No. 491-70-3
Storage powder
in solvent
Synonyms N/A
Smiles OC1=CC(=C2C(=O)C=C(OC2=C1)C3=CC=C(O)C(=C3)O)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation (Different batches have different solubility ratios, please contact Selleck to provide you with the correct ratio)
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    Would you please suggest a suitable vehicle to dissolve Luteolin for in vivo i.p. use?

  • Answer:

    Formula: 5% DMSO+40% PEG 300+5% Tween80+ddH2O, working Solution concentration: up to 7.5mg/ml, stable for 30min.

Tags: buy Luteolin | Luteolin supplier | purchase Luteolin | Luteolin cost | Luteolin manufacturer | order Luteolin | Luteolin distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID